Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inhalation exposure technology, dosimetry, and regulatory issues.

M A Dorato1, R K Wolff

  • 1Toxicology Division, Lilly Research Laboratories, Eli Lilly and Company, Greenfield, Indiana 46140.

Toxicologic Pathology
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toxicology Studies for Inhaled and Nasal Delivery.

Molecular pharmaceutics·2015
Same author

Folic acid pathway single nucleotide polymorphisms associated with methotrexate significant adverse events in United States veterans with rheumatoid arthritis.

Clinical and experimental rheumatology·2014
Same author

Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays.

Genome research·2000
Same author

Effects of inhalation exposures to an M1-receptor agonist on ventilation in rhesus monkeys.

Drug and chemical toxicology·1999
Same author

HFE genotype in patients with hemochromatosis and other liver diseases.

Annals of internal medicine·1999
Same author

Safety of inhaled proteins for therapeutic use.

Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine·1999
Same journal

New Approach Methodologies (NAMs) for Carcinogenicity Evaluation.

Toxicologic pathology·2026
Same journal

2025 International Academy of Toxicologic Pathology (IATP) Satellite Symposium: Pathology Working Groups (PWGs) in Toxicologic Pathology.

Toxicologic pathology·2026
Same journal

Toxicologic Pathology Forum*: Opportunities and Challenges in the Use of Artificial Intelligence in Nonclinical Toxicologic Histopathology Evaluations.

Toxicologic pathology·2026
Same journal

New Modalities and Carcinogenicity Assessment.

Toxicologic pathology·2026
Same journal

Second Joint Annual Congress of the British Society of Toxicologic Pathology and the European Society of Toxicologic Pathology Special Issue.

Toxicologic pathology·2026
Same journal

Hemangiosarcomas in Intercostal Brown Adipose Tissues of the Sternum Induced by Urethane in TgrasH2 Mice.

Toxicologic pathology·2026
See all related articles

Advances in inhalation toxicology technology offer improved exposure systems and environmental controls for studying inhaled toxicants. Key considerations include study design, dosimetry, and regulatory challenges for accurate toxicity assessments.

Area of Science:

  • Inhalation Toxicology
  • Environmental Health Science

Background:

  • Inhalation toxicology research has significantly advanced due to technological innovations.
  • Improved exposure systems and environmental controls enhance the study of inhaled toxicants.

Purpose of the Study:

  • To review recent technological advancements in inhalation toxicology.
  • To discuss practical challenges and considerations in designing and conducting inhalation studies.
  • To highlight regulatory issues impacting inhalation toxicity testing.

Main Methods:

  • Discussion of novel exposure systems (e.g., flow-past nose-only).
  • Analysis of environmental control methods within inhalation chambers.
  • Review of study design factors, including high-dose exposures and dosimetry.

Related Experiment Videos

Main Results:

  • New technologies enable more efficient and controlled inhalation exposure studies.
  • Understanding of factors like lung burden and clearance rates is crucial for accurate results.
  • Regulatory guidelines present specific challenges for study design, particularly for acute toxicity assessments.

Conclusions:

  • Technological progress in inhalation toxicology facilitates more robust scientific inquiry.
  • Careful consideration of exposure parameters, dosimetry, and regulatory requirements is essential for valid study outcomes.
  • Ongoing adaptation to regulatory demands is necessary for effective inhalation toxicity testing.